MAHE to set up Centre for Biotherapeutics Research

Our Bureau Mangaluru | Updated on March 17, 2021

Centre to focus its research mainly in the areas of cell, gene, protein, nano/biomaterial therapeutics

Manipal Academy of Higher Education (MAHE) will establish Manipal Centre for Biotherapeutics Research within a few months, according to the MAHE Vice-Chancellor, Lt Gen (retd) MD Venkatesh.

Stating that MAHE is an Institution of Eminence, he said it is exploring newer areas of education and research where it can take a lead. Active academia-industry collaboration is one of the areas of high priority for enhanced research output in the top-ranking universities.

He said in a media statement that some of the high-value biological drugs and devices were developed from such collaborations and licensed to biopharma companies globally.

“We have identified the need for MAHE to collaborate with biopharma companies to carry out innovative research, process and product development in the area of biotherapeutics,” he said.

Active collaboration

Raviraja NS, Coordinator of the centre and Director Corporate Relations, said that the overall aim of this centre is to carry out cutting edge research in the area of biotherapeutics in collaboration with biopharma industries.

This includes developing and filing commercially relevant patents that can be out-licensed to the biopharma companies, establishing active collaboration with biopharma companies to develop products and processes relevant to the industries, and facilitating biopharma companies to create collaborative research units at MAHE.

He said the centre will offer Masters and PhD programmes and house collaborate research units along with leading national and international biopharma companies. The centre is going to focus its research mainly in the areas of cell, gene, protein, nano/biomaterial therapeutics, he said.

An infrastructure to promote education and research along with the active collaboration of biopharma companies is being established to cater the research and product development needs. The centre will house two dedicated cGMP labs, four research labs and collaborative research units with biopharma companies, he said.

Published on March 17, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor